Exagen Inc.
XGN- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001274737
In the last 90 days, Exagen Inc. insiders filed 0 open-market purchases and 1 sale; 57 institutions reported holding it in 13F filings for Q2 2026, worth $37.0M in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding Exagen Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 30 | 31 | +1 |
| Shares | 6.59M | 6.20M | −389.0K (−5.9%) |
| Value | $13.1M | $9.87M | −$3.26M (−24.8%) |
New holders (1)
Institutions that held Exagen Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Palumbo Wealth Management LLC | 18,241 | $29.0K | 0.01% |
Sold out (0)
Institutions that held Exagen Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
None.